HydRx Farms
Experts in medical cannabis and pharmaceutical manufacturing with a focus on cannabinoid derivative products.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
CAD11.5m | Convertible | ||
| Total Funding | 000k | ||
HydRx Wellness operates as a vertically integrated Health Canada Licensed Producer specializing in the development and manufacturing of cannabinoid derivative products for both medical and adult use markets. With over a decade of industry experience, the company is strategically positioned in a 50,000 sq ft state-of-the-art facility in the Greater Toronto Area. HydRx Wellness serves medically authorized patients, provincially licensed bodies, and approved foreign entities by exporting bulk and finished cannabis goods. The business model revolves around pharmaceutical-grade manufacturing, including softgel, hot fill blisters, oils, liquids, and suppositories. Revenue is generated through the sale of cannabis-based products and pharmaceutical manufacturing services. The company benefits from the leadership of Mr. Serafino, a seasoned expert in MedTech and strategic planning, who contributes his extensive experience as Chairman of the Board. Key milestones include being first approved by Health Canada as a Controlled Drug Substances Licensed Dealer in October 2016.
Keywords: cannabis, pharmaceutical, manufacturing, cannabinoid, medical, adult use, Health Canada, export, softgel, wellness